BioAtla, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$6.23 | $223.86 M | -2.51 | 58 | $0 |
ADAG
Adagene Inc. |
$1.94 | $131.46 M | -6.77 | 174 | $18.11 M |
ANTX
AN2 Therapeutics, Inc. |
$1.36 | $60.55 M | -0.81 | 41 | $0 |
AVTE
Aerovate Therapeutics, Inc. |
$2.60 | $597.48 M | -6.84 | 51 | $0 |
CCCC
C4 Therapeutics, Inc. |
$3.87 | $320.64 M | -1.97 | 145 | $20.76 M |
DSGN
Design Therapeutics, Inc. |
$6.35 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$2.57 | $647.94 M | -2.83 | 126 | $0 |
FHTX
Foghorn Therapeutics Inc. |
$5.02 | $332.53 M | -2.73 | 116 | $34.16 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$7.05 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
IKNA
Ikena Oncology, Inc. |
$1.53 | $84.45 M | -1.11 | 14 | $9.16 M |
IPSC
Century Therapeutics, Inc. |
$1.03 | $244.54 M | -1.32 | 152 | $2.24 M |
KYMR
Kymera Therapeutics, Inc. |
$40.82 | $2.02 B | -13.13 | 184 | $78.59 M |
NAUT
Nautilus Biotechnology, Inc. |
$1.73 | $325.69 M | -4.81 | 161 | $0 |
NRIX
Nurix Therapeutics, Inc. |
$19.57 | $930.10 M | -5.89 | 284 | $76.99 M |
OLMA
Olema Pharmaceuticals, Inc. |
$6.32 | $734.41 M | -6.56 | 74 | $0 |
PASG
Passage Bio, Inc. |
$0.65 | $73.04 M | -0.77 | 58 | $0 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.47 | $85.40 M | -1.26 | 63 | $0 |
RZLT
Rezolute, Inc. |
$4.41 | $229.57 M | -5.02 | 59 | $0 |
STTK
Shattuck Labs, Inc. |
$1.11 | $333.81 M | -3.64 | 75 | $1.66 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |